104 related articles for article (PubMed ID: 10498355)
1. Dynamic profiles of interleukin-6 and the soluble form of CD25 in burned patients.
Peteiro-Cartelle FJ; Alvarez-Jorge A
Burns; 1999 Sep; 25(6):487-91. PubMed ID: 10498355
[TBL] [Abstract][Full Text] [Related]
2. Changes in circulating levels of interleukin 6 in burned patients.
Yeh FL; Lin WL; Shen HD; Fang RH
Burns; 1999 Mar; 25(2):131-6. PubMed ID: 10208387
[TBL] [Abstract][Full Text] [Related]
3. In the early stage of major burns, is there a correlation between survival, interleukin-6 levels and oxygen delivery and consumption?
Gueugniaud PY; Bertin-Maghit M; Hirschauer C; Bouchard C; Vilasco B; Petit P
Burns; 1997 Aug; 23(5):426-31. PubMed ID: 9426913
[TBL] [Abstract][Full Text] [Related]
4. [Serum levels of soluble CD25 (soluble interleukin 2 receptor) in asthmatic patients].
Shiota Y; Sato T; Ono T
Arerugi; 1993 Aug; 42(8):914-9. PubMed ID: 8250731
[TBL] [Abstract][Full Text] [Related]
5. Deficient transforming growth factor beta and interleukin-10 responses contribute to the septic death of burned patients.
Yeh FL; Shen HD; Fang RH
Burns; 2002 Nov; 28(7):631-7. PubMed ID: 12417156
[TBL] [Abstract][Full Text] [Related]
6. Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients.
Yeh FL; Lin WL; Shen HD
Burns; 2000 Aug; 26(5):454-9. PubMed ID: 10812267
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression follows systemic T lymphocyte activation in the burn patient.
Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Peters WJ
Clin Exp Immunol; 1991 Sep; 85(3):515-8. PubMed ID: 1893634
[TBL] [Abstract][Full Text] [Related]
8. Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system.
Jobin N; Garrel D; Bernier J
Hum Immunol; 2000 Mar; 61(3):233-46. PubMed ID: 10689113
[TBL] [Abstract][Full Text] [Related]
9. [Changes in serum contents of interleukin-6 and interleukin-10 and their relation with occurrence of sepsis and prognosis of severely burned patients].
Zhou H; Tu JJ; Huang Y; Chen XG; Deng YJ
Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):111-5. PubMed ID: 22781322
[TBL] [Abstract][Full Text] [Related]
10. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
[TBL] [Abstract][Full Text] [Related]
11. Changes in serum tumour necrosis factor-alpha in burned patients.
Yeh FL; Lin WL; Shen HD; Fang RH
Burns; 1997 Feb; 23(1):6-10. PubMed ID: 9115613
[TBL] [Abstract][Full Text] [Related]
12. Study of complement activation, C3 and interleukin-6 levels in burn patients and their role as prognostic markers.
Modi S; Rashid M; Malik A; Shahid M
Indian J Med Microbiol; 2014; 32(2):137-42. PubMed ID: 24713898
[TBL] [Abstract][Full Text] [Related]
13. Plasma tumor necrosis factor-alpha, its soluble receptors and interleukin-1beta levels in critically burned patients.
Zhang B; Huang YH; Chen Y; Yang Y; Hao ZL; Xie SL
Burns; 1998 Nov; 24(7):599-603. PubMed ID: 9882056
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the expression of three markers in T lymphocytes of peripheral blood and immunoregulatory mechanisms of burned mice with sepsis at early stage].
Zhou Y; Huang P; Zhang P; Ren L; Zeng J; Zhou J; Liang P; Huang X
Zhonghua Shao Shang Za Zhi; 2016 Feb; 32(2):89-96. PubMed ID: 26902275
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course.
Swaak AJ; Hintzen RQ; Huysen V; van den Brink HG; Smeenk JT
Clin Rheumatol; 1995 May; 14(3):293-300. PubMed ID: 7641505
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn.
Kim BS; Stoppe C; Grieb G; Leng L; Sauler M; Assis D; Simons D; Boecker AH; Schulte W; Piecychna M; Hager S; Bernhagen J; Pallua N; Bucala R
Burns; 2016 Sep; 42(6):1265-76. PubMed ID: 27209369
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency department.
García de Guadiana-Romualdo L; Berger M; Jiménez-Santos E; Rebollo-Acebes S; Jiménez-Sánchez R; Esteban-Torrella P; Hernando-Holgado A; Ortín-Freire A; Albaladejo-Otón MD
Eur J Clin Invest; 2017 Apr; 47(4):297-304. PubMed ID: 28155994
[TBL] [Abstract][Full Text] [Related]
18. Burn trauma induces early HMGB1 release in patients: its correlation with cytokines.
Lantos J; Földi V; Roth E; Wéber G; Bogár L; Csontos C
Shock; 2010 Jun; 33(6):562-7. PubMed ID: 19997053
[TBL] [Abstract][Full Text] [Related]
19. Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression.
Bogner MP; Voss SD; Bechhofer R; Hank JA; Roper M; Poplack D; Hammond D; Sondel PM
J Immunother (1991); 1992 Feb; 11(2):111-8. PubMed ID: 1571333
[TBL] [Abstract][Full Text] [Related]
20. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis].
Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X
Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
